CARGO elects to discontinue FIRCE-1, a Phase 2 clinical study of firicabtagene autoleucel (firi-cel)1; Company believes results do not support a ...
The Boeing Company faces short-term struggles with negative operating cash flow, but it has a strong cash position and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback